Although several compounds have been identified as ferroptosis inducers, and novel drug delivery systems (such as exosomes and nanotechnology) are being explored to enhance drug delivery into cells, the clinical application of these strategies faces significant challenges
Semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have experienced especially strong uptake following their FDA approvals
In a first multicentered real-world study assessing the weight loss and metabolic outcomes of semaglutide, we demonstrated effective weight-loss outcomes and associated comorbidity profile improvement in patients with overweight or obesity, Wissam Ghusn, MD, a postdoctoral research fellow in the Precision Medicine for Obesity Program at the Mayo Clinic in Rochester, Minnesota, told Healio
Do you offer wellness products outside of IV therapy
Should I consider an SGLT2 inhibitor instead of or in addition to a GLP-1 medication, especially if I have heart failure or kidney disease